A new study that looked at how liberal vs. restrictive fluid restriction impacts health status for patients with chronic ...

A U.S. court has brought back a patent infringement case between Getinge's Maquet and Johnson & Johnson's Abiomed.

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for ...

Johnson & Johnson (NYSE:JNJ) holds one of the longest dividend growth track records in the market, spanning over 62 years.

Developers of cardiology drugs and devices will be back in the spotlight this weekend when the annual scientific meeting of ...

Actavis Labs. FL, Inc. v. United States, Appeal No. 2023-1320 (Fed. Cir. Mar. 21, 2025) Our Case of the Week, in the words of ...

CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...